[Highlights of the Congress of the National Infectious Disease Medicine Days 2010]

Med Mal Infect. 2011 Jan;41(1 Suppl 1):H6-10. doi: 10.1016/S0399-077X(11)70004-X.
[Article in French]
No abstract available

Publication types

  • Congress

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Arthritis, Infectious / drug therapy
  • Aza Compounds / administration & dosage
  • Aza Compounds / therapeutic use
  • Bacterial Infections / drug therapy*
  • Chemical and Drug Induced Liver Injury / etiology
  • Clinical Trials as Topic / methods
  • Drug Resistance, Microbial
  • Fluoroquinolones
  • France
  • Humans
  • Infectious Disease Medicine*
  • Moxifloxacin
  • Multicenter Studies as Topic
  • Osteitis / drug therapy
  • Prosthesis-Related Infections / drug therapy
  • Quinolines / administration & dosage
  • Quinolines / therapeutic use
  • Societies, Medical
  • Treatment Outcome
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • beta-Lactamases
  • Moxifloxacin